Show simple item record

dc.creatorSafe, Stephen H.
dc.creatorChintharlapalli, Sudhakar
dc.creatorMcalees, Alan
dc.creatorMccrindle, Robert
dc.date.accessioned2019-06-17T17:07:18Z
dc.date.available2019-06-17T17:07:18Z
dc.date.issued2013-03-05
dc.identifier.urihttps://hdl.handle.net/1969.1/177024
dc.description.abstractThe present invention relates to novel derivatives of glycyrrhetinic acid, compositions comprising said derivatives and their use in the treatment of conditions or diseases that benefit from an upregulation of PPAR&ggr and/or a downregulation of the expression or activity of one or more specificity (Sp) proteins, such as cancer, diabetes and Huntington's disease.en
dc.languageeng
dc.publisherUnited States. Patent and Trademark Office
dc.rightsPublic Domain (No copyright - United States)en
dc.rights.urihttp://rightsstatements.org/vocab/NoC-US/1.0/
dc.titleGlycyrrhetinic acid derivativesen
dc.typeUtility patenten
dc.format.digitalOriginreformatted digitalen
dc.description.countryUS
dc.contributor.assigneeWellington Laboratories Inc.
dc.contributor.assigneeThe Texas A&M University System
dc.identifier.patentapplicationnumber12/308798
dc.subject.uspcprimary514/510
dc.subject.uspcother560/116
dc.date.filed2007-06-27
dc.publisher.digitalTexas A&M University. Libraries
dc.subject.cpcprimaryA61P 1/00
dc.subject.cpcprimaryA61P 25/14
dc.subject.cpcprimaryA61P 1/18
dc.subject.cpcprimaryA61K 31/122
dc.subject.cpcprimaryA61P 25/00
dc.subject.cpcprimaryA61P 3/10
dc.subject.cpcprimaryA61P 13/08
dc.subject.cpcprimaryA61P 25/28
dc.subject.cpcprimaryA61P 35/00
dc.subject.cpcprimaryC07J 63/008
dc.subject.cpcprimaryA61P 43/00


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record